Delivery Order SPE2DB25D3404-SPE2DB25FUNQL

Award Date 5/29/25
Potential Completion Date 5/30/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,753.60, is for the delivery of 4568387549 PROVISC 10 MG/ML DISP SYRNG 0.85ML, a pharmaceutical product. The contract is for a firm fixed price and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,665.80, is a Firm Fixed Price Delivery Order for the supply of PROVISC 10 MG/ML DISP SYRNG 0.55ML medical syringes. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,221.40 firm fixed-price delivery order is for the supply of 4566450347 - Provisc 10 mg/ml Dispersible Syringes (0.55 ml). The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,970.86 firm fixed-price delivery order is for the supply of 4,568,252,839 milliliters of Provisc 10 mg/ml disposable syringes. The contract has an ultimate completion date of May 15, 2025 and is not set aside for any particular business type. AmerisourceBergen holds a significant $999,999,999.00 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the supply of a pharmaceutical product, Provisc 10 mg/ml Disposable Syringe 0.55 ml, to a Defense agency, the Medical Supply Chain of the Defense Logistics Agency (DLA). The $4,483.00 firm fixed-price delivery order has a completion date of June 20, 2024 and does not utilize a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, a division of the Amerisourcebergen Corporation, is for the provision of a pharmaceutical product, specifically 4564730315 ! PROVISC 10 MG/ML DISP SYRNG 0.85ML. The contract has a ceiling value of $3,903.68 and is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, valued up to $999,999,999.00 through December 31, 2025, serves...
This federal contract award, with a ceiling value of $2,855.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROVISC 10 MG/ML DISP SYRNG 0.55ML, a medical supply product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of May 9, 2025. It is not designated as a set-aside contract, indicating open...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of PROVISC 10 MG/ML DISP SYRNG 0.55ML. The contract, valued at $6,046.20, was awarded on June 26, 2024 by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and has a completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4566054025 PROVISC 10 MG/ML DISP SYRNG 0.55ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,605.60 and an ultimate completion date of October 9, 2024. This contract is not set aside for any specific business category. AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,068.05 firm fixed-price delivery order is for the supply of 0.5 mL VISCOAT syringes, with a performance period extending through May 7, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUNQL
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,906.20 firm fixed price delivery order is for the supply of PROVISC 10 MG/ML DISP SYRNG 0.55ML, a medical product. The contract has an ultimate completion date of May 30, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

This contract award is not set aside and is open to full and open competition.

Generated 8/28/25, 9:51 AM